Emil U. Hermansen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.
Journal: Blood cancer journal
Published: November 06, 2025
Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis.
Journal: Blood cancer journal
Published: May 27, 2025
Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group.
Journal: British journal of haematology
Published: March 19, 2025
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis.
Journal: Blood cancer journal
Published: February 14, 2025
Isatuximab, bortezomib, lenalidomide, and limited dexamethasone in patients with transplant-ineligible multiple myeloma (REST): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Haematology
Published: September 11, 2024
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
Journal: European journal of haematology
Published: August 15, 2022
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Journal: American journal of hematology
Published: September 10, 2021
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Journal: Hematological oncology
Published: June 11, 2021
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Journal: European journal of haematology
Published: April 02, 2021
The real-world outcomes of multiple myeloma patients treated with daratumumab.
Journal: PloS one
Published: March 19, 2021
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Journal: Blood cancer journal
Published: December 10, 2020
Last Updated: 09/26/2026